VIVANI MEDICAL, INC. Financials Vivani Medical, Inc.
Equities
VANI
US92854B1098
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.91 USD | +4.37% |
|
0.00% | +87.25% |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 43.11 | 52.05 | 96.76 | - | - |
| Enterprise Value (EV) 1 | 43.11 | 52.05 | 96.76 | 96.76 | 96.76 |
| P/E ratio | - | -2.04 x | -3.52 x | -3.14 x | -2.89 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - |
| EV / EBITDA | -2,066,643 x | - | - | - | - |
| EV / FCF | -2,254,127 x | - | - | - | - |
| FCF Yield | -0% | - | - | - | - |
| Price to Book | - | - | - | - | - |
| Nbr of stocks (in thousands) | 50,736 | 51,025 | 54,978 | - | - |
| Reference price 2 | 0.8497 | 1.020 | 1.760 | 1.760 | 1.760 |
| Announcement Date | 3/31/23 | 3/26/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | - |
| EBITDA | - | -20.86 | - | - | - | - |
| EBIT 1 | - | -21.24 | -26.96 | -27.09 | -31.56 | -36.87 |
| Operating Margin | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | - | - | -25.65 | -27.09 | -31.56 | -36.87 |
| Net income 1 | -12.77 | - | -25.65 | -27.09 | -31.56 | -36.87 |
| Net margin | - | - | - | - | - | - |
| EPS 2 | -1.170 | - | -0.5000 | -0.5000 | -0.5600 | -0.6100 |
| Free Cash Flow | - | -19.12 | - | - | - | - |
| FCF margin | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 6/24/22 | 3/31/23 | 3/26/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | - | -7.003 | -7.144 | -6.217 | -6.227 | -6.468 | -6.989 | -7.291 |
| Operating Margin | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | - | -6.526 | -6.782 | -6.026 | -6.039 | -6.468 | -6.989 | -7.291 |
| Net income 1 | -6.318 | -6.526 | -6.782 | -6.026 | -6.039 | -6.468 | -6.989 | -7.291 |
| Net margin | - | - | - | - | - | - | - | - |
| EPS 2 | -0.1200 | -0.1300 | -0.1300 | -0.1200 | -0.1200 | -0.1200 | -0.1300 | -0.1300 |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 5/15/23 | 8/14/23 | 11/13/23 | 3/26/24 | 5/13/24 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow | - | -19.1 | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - |
| Announcement Date | 6/24/22 | 3/31/23 | 3/26/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.76
USD
Average target price
8
USD
Spread / Average Target
+354.55%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +87.25% | 98.14M | |
| +12.01% | 126B | |
| -5.89% | 11.3B | |
| +6.26% | 9.16B | |
| +35.53% | 5.46B | |
| +8.68% | 3.45B | |
| -8.89% | 2.76B | |
| -10.68% | 2.09B | |
| -10.77% | 2B | |
| -26.31% | 1.77B |
- Stock Market
- Equities
- VANI Stock
- Financials Vivani Medical, Inc.
